Reduced expression of C/EBPβ-LIP extends health- and lifespan in mice

  1. Christine Müller
  2. Laura M Zidek
  3. Tobias Ackermann
  4. Tristan de Jong
  5. Peng Liu
  6. Verena Kliche
  7. Mohamad Amr Zaini
  8. Gertrud Kortman
  9. Liesbeth Harkema
  10. Dineke S Verbeek
  11. Jan P Tuckermann
  12. Julia von Maltzahn
  13. Alain de Bruin
  14. Victor Guryev
  15. Zhao-Qi Wang
  16. Cornelis F Calkhoven  Is a corresponding author
  1. University Medical Center Groningen, Netherlands
  2. Leibniz Institute on Ageing - Fritz Lipmann Institute, Germany
  3. University of Ulm, Germany
  4. Utrecht University, Netherlands

Abstract

Ageing is associated with physical decline and the development of age-related diseases such as metabolic disorders and cancer. Few conditions are known that attenuate the adverse effects of ageing, including calorie restriction (CR) and reduced signalling through the mechanistic target of rapamycin complex 1 (mTORC1) pathway. Synthesis of the metabolic transcription factor C/EBPβ-LIP is stimulated by mTORC1, which critically depends on a short upstream open reading frame (uORF) in the Cebpb-mRNA. Here we describe that reduced C/EBPβ-LIP expression due to genetic ablation of the uORF delays the development of age-associated phenotypes in mice. Moreover, female C/EBPβΔuORF mice display an extended lifespan. Since LIP levels increase upon aging in wild type mice, our data reveal an important role for C/EBPβ in the aging process and suggest that restriction of LIP expression sustains health and fitness. Thus, therapeutic strategies targeting C/EBPβ-LIP may offer new possibilities to treat age-related diseases and to prolong healthspan.

Data availability

For transcriptome dataset see: Müller, C., de Jong, T, Guryev, V, Calkhoven, CF. (2018). Transcriptome profiling of liver samples of C/EBPβΔuORF mice. Retrieved from: https://www.ebi.ac.uk/arrayexpress/

The following data sets were generated

Article and author information

Author details

  1. Christine Müller

    European Research Institute for the Biology of Ageing, University Medical Center Groningen, Groningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  2. Laura M Zidek

    Leibniz Institute on Ageing - Fritz Lipmann Institute, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Tobias Ackermann

    European Research Institute for the Biology of Ageing, University Medical Center Groningen, Groningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  4. Tristan de Jong

    European Research Institute for the Biology of Ageing, University Medical Center Groningen, Groningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  5. Peng Liu

    Institute of Comparative Molecular Endocrinology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Verena Kliche

    Leibniz Institute on Ageing - Fritz Lipmann Institute, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Mohamad Amr Zaini

    European Research Institute for the Biology of Ageing, University Medical Center Groningen, Groningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  8. Gertrud Kortman

    European Research Institute for the Biology of Ageing, University Medical Center Groningen, Groningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  9. Liesbeth Harkema

    Dutch Molecular Pathology Centre, Utrecht University, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  10. Dineke S Verbeek

    Department of Genetics, University Medical Center Groningen, Groningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  11. Jan P Tuckermann

    Institute of Comparative Molecular Endocrinology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Julia von Maltzahn

    Leibniz Institute on Ageing - Fritz Lipmann Institute, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  13. Alain de Bruin

    Dutch Molecular Pathology Centre, Utrecht University, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  14. Victor Guryev

    European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University Medical Center Groningen, Groningen, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  15. Zhao-Qi Wang

    Leibniz Institute on Ageing - Fritz Lipmann Institute, Jena, Germany
    Competing interests
    The authors declare that no competing interests exist.
  16. Cornelis F Calkhoven

    European Research Institute for the Biology of Ageing, University Medical Center Groningen, Groningen, Netherlands
    For correspondence
    c.f.calkhoven@umcg.nl
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6318-7210

Funding

Deutsche Forschungsgemeinschaft (CA 283/1-1)

  • Laura M Zidek
  • Cornelis F Calkhoven

Leibniz-Gemeinschaft (LGSA)

  • Tobias Ackermann
  • Cornelis F Calkhoven

Deutsche Forschungsgemeinschaft (MA 3975/2-1)

  • Laura M Zidek
  • Julia von Maltzahn

Deutsche Forschungsgemeinschaft (INST 40/492-1)

  • Peng Liu
  • Jan P Tuckermann

Deutsche Forschungsgemeinschaft (TU 220/6)

  • Peng Liu
  • Jan P Tuckermann

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of the Thüringer Landesamt für Verbraucherschutz (#03-005/13) and University of Groningen (#6996A).

Copyright

© 2018, Müller et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,210
    views
  • 868
    downloads
  • 21
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Christine Müller
  2. Laura M Zidek
  3. Tobias Ackermann
  4. Tristan de Jong
  5. Peng Liu
  6. Verena Kliche
  7. Mohamad Amr Zaini
  8. Gertrud Kortman
  9. Liesbeth Harkema
  10. Dineke S Verbeek
  11. Jan P Tuckermann
  12. Julia von Maltzahn
  13. Alain de Bruin
  14. Victor Guryev
  15. Zhao-Qi Wang
  16. Cornelis F Calkhoven
(2018)
Reduced expression of C/EBPβ-LIP extends health- and lifespan in mice
eLife 7:e34985.
https://doi.org/10.7554/eLife.34985

Share this article

https://doi.org/10.7554/eLife.34985

Further reading

    1. Cell Biology
    2. Plant Biology
    Baihong Zhang, Shuqin Huang ... Wenli Chen
    Research Article

    Autophagy-related gene 6 (ATG6) plays a crucial role in plant immunity. Nonexpressor of pathogenesis-related genes 1 (NPR1) acts as a signaling hub of plant immunity. However, the relationship between ATG6 and NPR1 is unclear. Here, we find that ATG6 directly interacts with NPR1. ATG6 overexpression significantly increased nuclear accumulation of NPR1. Furthermore, we demonstrate that ATG6 increases NPR1 protein levels and improves its stability. Interestingly, ATG6 promotes the formation of SINCs (SA-induced NPR1 condensates)-like condensates. Additionally, ATG6 and NPR1 synergistically promote the expression of pathogenesis-related genes. Further results showed that silencing ATG6 in NPR1-GFP exacerbates Pst DC3000/avrRps4 infection, while double overexpression of ATG6 and NPR1 synergistically inhibits Pst DC3000/avrRps4 infection. In summary, our findings unveil an interplay of NPR1 with ATG6 and elucidate important molecular mechanisms for enhancing plant immunity.

    1. Cell Biology
    Chengfang Pan, Ying Liu ... Changlong Hu
    Research Article

    Prostaglandin E2 (PGE2) is an endogenous inhibitor of glucose-stimulated insulin secretion (GSIS) and plays an important role in pancreatic β-cell dysfunction in type 2 diabetes mellitus (T2DM). This study aimed to explore the underlying mechanism by which PGE2 inhibits GSIS. Our results showed that PGE2 inhibited Kv2.2 channels via increasing PKA activity in HEK293T cells overexpressed with Kv2.2 channels. Point mutation analysis demonstrated that S448 residue was responsible for the PKA-dependent modulation of Kv2.2. Furthermore, the inhibitory effect of PGE2 on Kv2.2 was blocked by EP2/4 receptor antagonists, while mimicked by EP2/4 receptor agonists. The immune fluorescence results showed that EP1–4 receptors are expressed in both mouse and human β-cells. In INS-1(832/13) β-cells, PGE2 inhibited voltage-gated potassium currents and electrical activity through EP2/4 receptors and Kv2.2 channels. Knockdown of Kcnb2 reduced the action potential firing frequency and alleviated the inhibition of PGE2 on GSIS in INS-1(832/13) β-cells. PGE2 impaired glucose tolerance in wild-type mice but did not alter glucose tolerance in Kcnb2 knockout mice. Knockout of Kcnb2 reduced electrical activity, GSIS and abrogated the inhibition of PGE2 on GSIS in mouse islets. In conclusion, we have demonstrated that PGE2 inhibits GSIS in pancreatic β-cells through the EP2/4-Kv2.2 signaling pathway. The findings highlight the significant role of Kv2.2 channels in the regulation of β-cell repetitive firing and insulin secretion, and contribute to the understanding of the molecular basis of β-cell dysfunction in diabetes.